Home - Products - Immunology/Inflammation - TLR - Rabeximod

Rabeximod

CAS No. 872178-65-9

Rabeximod( —— )

Catalog No. M34686 CAS No. 872178-65-9

Rabeximod is a potent immunomodulator that reduces the severity of autoimmune diseases in rat models.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	392	Get Quote
5MG	610	Get Quote
10MG	867	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Rabeximod
Note

Research use only, not for human use.
Brief Description

Rabeximod is a potent immunomodulator that reduces the severity of autoimmune diseases in rat models.
Description

Rabeximod is a potent immunomodulator that reduces the severity of autoimmune diseases in rat models. Rabeximod inhibits arthritis in a time-dependent manner by stimulating TLR2 and TLR4 downstream to block the activation of inflammatory cells, most likely macrophages. Rabeximod effectively reduces brain antigen presentation in mice during anti-inflammatory therapy for traumatic brain injury.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Immunology/Inflammation
Target

TLR
Recptor

TLR
Research Area

——
Indication

——

Chemical Information

CAS Number

872178-65-9
Formula Weight

409.91
Molecular Formula

C22H24ClN5O
Purity

>98% (HPLC)
Solubility

——
SMILES

C(C(NCCN(C)C)=O)N1C=2C(C=3C1=CC=C(Cl)C3)=NC=4C(N2)=CC(C)=C(C)C4
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

SM360320

SM360320 is an effective and selective agonist of TLR7. SM360320 inhibits HCV replication in hepatocytes via a type I IFN-independent mechanism in addition to its IFN-mediated activity.
Hydroxychloroquine

Hydroxychloroquine (HCQ) is an alkalinizing lysosomatropic drug that acts by inducing apoptosis of renal cancer cells in vitro and inhibiting TLR7/9.
CU-CPD107

CU-CPD107 is a selective agonist of toll-like receptor 8 (TLR8) and also shows activation activity against ssRNA ligands. CU-CPD107 acts as an inhibitor of TLR8 signaling in the presence of R848 (IC50=13.7 μM).

Sign In Join Free